派杰桑德勒看好生物科技板块进入新一轮上升周期,推荐17只值得持有的股票
- Investing.com
| MRNA | 5.67% | 52.40 | -2.84% | 2,372,096 | |
| GILD | 4.43% | 141.29 | -2.15% | 671,885 | |
| AMGN | 4.16% | 351.48 | -2.67% | 249,471 | |
| UTHR | 4.11% | 530.35 | -1.79% | 168,325 | |
| EXAS | 3.76% | 103.75 | -0.18% | 796,833 | |
| VRTX | 3.75% | 451.59 | -2.36% | 175,372 | |
| BMRN | 3.68% | 55.43 | -1.11% | 1,380,146 | |
| BIIB | 3.58% | 182.31 | -1.61% | 433,656 | |
| NBIX | 3.54% | 130.71 | 0.00% | 599,181 | |
| KRYS | 3.50% | 250.83 | -2.15% | 311,234 |